市場調査レポート
商品コード
1575552

アジア太平洋のメタゲノミクス市場：タイプ別、用途別、国別 - 分析と予測（2024年～2033年）

Asia-Pacific Metagenomics Market: Focus on Type, Application, and Country - Analysis and Forecast, 2024-2033
表紙：アジア太平洋のメタゲノミクス市場：タイプ別、用途別、国別 - 分析と予測（2024年～2033年）

出版日
発行
BIS Research
ページ情報
英文 70 Pages
納期
1～5営業日
カスタマイズ可能
アジア太平洋のメタゲノミクス市場：タイプ別、用途別、国別 - 分析と予測（2024年～2033年）
出版日: 2024年10月22日
発行: BIS Research
ページ情報: 英文 70 Pages
納期: 1～5営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 図表
  • 目次
概要

アジア太平洋のメタゲノミクスの市場規模は、2023年に3億7,610万米ドルとなりました。

同市場は、2024年から2033年にかけて19.65%のCAGRで拡大し、2033年には22億3,800万米ドルに達すると予測されています。アジア太平洋のメタゲノミクス市場は、実験室では培養できない微生物群を調べることができるため、急速に拡大しています。ゲノム解析手法を用いて環境サンプルから直接微生物ゲノムを研究することで、メタゲノミクスは微生物の多様性と機能に関する知識に革命をもたらしています。シーケンシング技術の向上、微生物の健康への影響に関する知識の増加、バイオテクノロジー、農業、環境保全などの産業におけるメタゲノミクスの広範な利用が、この市場成長の主な促進要因となっています。

新規の酵素や抗生物質に対する需要や、オーダーメイド医療に対する関心の高まりが、アジア太平洋における市場拡大の原動力となっています。メタゲノミクスは、微生物生態系に関する重要な情報を明らかにする能力を備えているため、科学研究と商業応用の両方にとって不可欠なツールになりつつあります。

主要市場統計
予測期間 2024年～2033年
2024年の評価 4億4,540万米ドル
2033年の予測 22億3,800万米ドル
CAGR 19.65%

アジア太平洋におけるメタゲノミクス市場は、微生物群を理解するための高度なゲノム解析に対するニーズの高まりにより、大きく拡大しています。微生物の多様性と役割に関する我々の理解は、環境サンプルから直接微生物ゲノムを解析することを可能にするメタゲノミクスによって完全に変化しました。これは特に、従来の実験室での培養技術が容易に利用できない地域で顕著です。その結果、APACではヘルスケア、農業、バイオテクノロジー、環境管理など、多くの分野で顕著な進歩が見られるようになっています。

この市場は主に、バイオインフォマティクス・ツールと次世代シーケンシング（NGS）技術の開拓によって牽引されています。メタゲノミクスの研究と応用は、人間の健康、農業生産性、環境修復に対する微生物の影響に対する認識の高まりによってさらに刺激されています。また、新興国市場に対処する必要性、テーラーメイド治療の必要性、新しい抗生物質の開発も市場の成長に拍車をかけています。

当レポートでは、アジア太平洋のメタゲノミクス市場について調査し、市場の概要とともに、タイプ別、用途別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

  • エコシステムの概要：メタゲノミクス市場
  • 動向：現在および将来の影響評価
  • 研究開発レビュー
  • 規制状況
  • 市場力学

第2章 地域

  • 地域別概要
  • 促進要因と抑制要因
  • アジア太平洋

第3章 市場-競合ベンチマーキングと企業プロファイル

  • 今後の見通し
  • エコシステムにおいて活躍する主要参入企業
  • 主な戦略と開発
    • BGI Genomics
    • MGI Tech Co., Ltd.
    • Macrogen, Inc.
    • メタゲノミクス市場の新興企業

第4章 調査手法

図表

List of Figures

  • Figure 1: Asia-Pacific Metagenomics Market, $Million, 2024, 2028 and 2033
  • Figure 2: Metagenomics Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 3: Asia-Pacific Metagenomics Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Asia-Pacific Metagenomics Market (by Clinical Diagnostics), $Million, 2023, 2027, and 2033
  • Figure 5: Asia-Pacific Metagenomics Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 6: Key Industrial Developments in Metagenomics Market, 2023-2024
  • Figure 7: Ecosystem Overview and Operational Challenges
  • Figure 8: Applications of Metagenomics in Different Research Areas
  • Figure 9: Strategies Undertaken by Key Players, 2021-2024
  • Figure 10: Strategic Collaborations and Partnerships, January 2021-April 2024
  • Figure 11: Number of Metagenomics Patents (by Country), January 2020-April 2024
  • Figure 12: Number of Metagenomics Patents (by Year), January 2020-December 2023
  • Figure 13: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 14: Sequencing Cost over Time, 2007, 2014 and 2023
  • Figure 15: Increase in Number of Metagenomics Publications, 2019-2023
  • Figure 16: Estimated Number of Incident Tuberculosis Cases, Globally, Million, 2016 and 2021
  • Figure 17: Incidence of Influenza A and B in India, Million, 2022-2033
  • Figure 18: Increase in Metagenomics Research and Infectious Disease Publications, 2019-2023
  • Figure 19: Advancements in the Metagenomics Market (by Technology)
  • Figure 20: Challenges Related to Storing Sequenced Data
  • Figure 21: Global Plastic Pollution, 1950-2050
  • Figure 22: Forecasted Death Rates from Antimicrobial Resistance Vs. Current Leading Causes of Mortality
  • Figure 23: China Metagenomics Market, $Million, 2023-2033
  • Figure 24: Japan Metagenomics Market, $Million, 2023-2033
  • Figure 25: India Metagenomics Market, $Million, 2023-2033
  • Figure 26: Australia Metagenomics Market, $Million, 2023-2033
  • Figure 27: South Korea Metagenomics Market, $Million, 2023-2033
  • Figure 28: Rest-of-Asia-Pacific Metagenomics Market, $Million, 2023-2033
  • Figure 29: Strategic Initiatives, 2021-2024
  • Figure 30: Share of Strategic Initiatives, 2021-2024
  • Figure 31: Strategic Initiatives (by Year), 2021-2024
  • Figure 32: Data Triangulation
  • Figure 33: Top-Down and Bottom-Up Approach
  • Figure 34: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Metagenomics Market, Market Opportunities
  • Table 3: Key Trends, Metagenomics Market
  • Table 4: Examples of Metagenomics in New Applications
  • Table 5: Regulatory Scenario of Metagenomics
  • Table 6: Different Generations of NGS Platforms Showing Technological Advancements
  • Table 7: Metagenomics Market (by Region), $Million, 2023-2033
  • Table 8: Asia-Pacific Metagenomics Market (by Type), $Million, 2023-2033
  • Table 9: Asia-Pacific Metagenomics Market (by Application), $Million, 2023-2033
  • Table 10: China Metagenomics Market (by Type), $Million, 2023-2033
  • Table 11: China Metagenomics Market (by Application), $Million, 2023-2033
  • Table 12: Japan Metagenomics Market (by Type), $Million, 2023-2033
  • Table 13: Japan Metagenomics Market (by Application), $Million, 2023-2033
  • Table 14: India Metagenomics Market (by Type), $Million, 2023-2033
  • Table 15: India Metagenomics Market (by Application), $Million, 2023-2033
  • Table 16: Australia Metagenomics Market (by Type), $Million, 2023-2033
  • Table 17: Australia Metagenomics Market (by Application), $Million, 2023-2033
  • Table 18: South Korea Metagenomics Market (by Type), $Million, 2023-2033
  • Table 19: South Korea Metagenomics Market (by Application), $Million, 2023-2033
  • Table 20: Rest-of-Asia-Pacific Metagenomics Market (by Type), $Million, 2023-2033
  • Table 21: Rest-of-Asia-Pacific Metagenomics Market (by Application), $Million, 2023-2033
  • Table 22: Some of the Key Players in Metagenomics Market
  • Table 23: Emerging Companies in Metagenomics Market
目次
Product Code: BHP2364SS

Introduction to Asia-Pacific (APAC) Metagenomics Market

The Asia-Pacific metagenomics market was valued at $376.1 million in 2023 and is expected to reach $2,238.0 million by 2033, growing at a CAGR of 19.65% between 2024 and 2033. The metagenomics market in Asia-Pacific (APAC) is expanding rapidly, driven by its ability to examine microbial communities that cannot be grown in laboratory. By studying microbial genomes directly from environmental samples using genomic analysis methods, metagenomics is revolutionizing our knowledge of microbial diversity and function. Improvements in sequencing technologies, growing knowledge of the health effects of microbes, and the widespread use of metagenomics in industries including biotechnology, agriculture, and environmental preservation are major drivers of this market's growth.

The demand for novel enzymes and antibiotics, as well as the growing interest in customized medicine, are driving the market's expansion in Asia Pacific. Metagenomics is becoming an essential tool for both scientific research and commercial applications because of its capacity to reveal important information about microbial ecosystems.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$445.4 Million
2033 Forecast$2,238.0 Million
CAGR19.65%

Market Introduction

The market for metagenomics in Asia-Pacific (APAC) is expanding significantly due to the growing need for sophisticated genomic analysis to comprehend microbial populations. Our understanding of microbial diversity and roles has been completely transformed by metagenomics, which makes it possible to analyze microbial genomes directly from environmental samples. This is particularly true in areas where conventional lab culture techniques are not readily available. As a result, APAC has seen notable advancements in a number of areas, including healthcare, agriculture, biotechnology, and environmental management.

This market is primarily driven by developments in bioinformatics tools and next-generation sequencing (NGS) technology. Metagenomics research and applications have been further stimulated by the increasing recognition of the effects of microbes on human health, agricultural productivity, and environmental restoration. The need to address developing diseases, the need for tailored therapy, and the development of new antibiotics have also spurred the market's growth.

Furthermore, the metagenomics market is expected to grow steadily as APAC economies make significant investments in scientific research and development. The technology is a vital tool for innovation in sectors that depend on an understanding of microbiomes for sustainable solutions because of its unrealized potential in analyzing complex microbial ecosystems.

Market Segmentation

Segmentation 1: by Product Type

  • Consumables
  • Instruments
  • Services and Software

Segmentation 2: by Application

  • Clinical Diagnostics
  • Industrial Applications
  • Research Applications

Segmentation 3: by Country

  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The APAC metagenomics market has been segmented based on various categories, such as product type, workflow, technology, application, and country.

Competitive Strategy: Key players are investing heavily in research and development to enhance their product portfolios and develop cutting-edge technologies for sample preparation, sequencing, and analysis. Strategic collaborations with academic institutions, research organizations, and industry partners are also key, facilitating access to diverse datasets and expertise. Furthermore, companies are focusing on expanding their market presence through geographic expansion and strategic acquisitions to capitalize on emerging opportunities and consolidate their market position.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • BGI Genomics
  • MGI Tech Co., Ltd.
  • Macrogen, Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Ecosystem Overview: Metagenomics Market
  • 1.2 Trends: Current and Future Impact Assessment
    • 1.2.1 Expansion into New Application Areas
    • 1.2.2 Increasing Collaborations and Partnerships among Key Players
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Company)
  • 1.4 Regulatory Landscape
  • 1.5 Market Dynamics
    • 1.5.1 Market Drivers
      • 1.5.1.1 Significant Reduction in Sequencing Costs Leading to an Increase in the Number of Metagenomics Studies
      • 1.5.1.2 High Incidence of Infectious Diseases
      • 1.5.1.3 Technological Advancements in Metagenomics
    • 1.5.2 Market Restraints
      • 1.5.2.1 Challenge of Securely Storing Vast Volumes of Sequenced Data
      • 1.5.2.2 Challenges Involved in Data Analysis of Metagenomics Sequencing and Lack of Clear Knowledge
    • 1.5.3 Market Opportunities
      • 1.5.3.1 Opportunity for Metagenomics in Microplastic Remediation
      • 1.5.3.2 Focus on Metagenomics Research on Antibiotic-Resistant Bacteria and Antibiotic-Resistant Genes

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Factors Driving the Market Growth
    • 2.3.3 Factors Impeding/Limiting the Market Growth
    • 2.3.4 By Type
    • 2.3.5 By Application
    • 2.3.6 China
      • 2.3.6.1 By Type
      • 2.3.6.2 By Application
    • 2.3.7 Japan
      • 2.3.7.1 By Type
      • 2.3.7.2 By Application
    • 2.3.8 India
      • 2.3.8.1 By Type
      • 2.3.8.2 By Application
    • 2.3.9 Australia
      • 2.3.9.1 By Type
      • 2.3.9.2 By Application
    • 2.3.10 South Korea
      • 2.3.10.1 By Type
      • 2.3.10.2 By Application
    • 2.3.11 Rest-of-Asia-Pacific
      • 2.3.11.1 By Type
      • 2.3.11.2 By Application

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Active Key Players in The Ecosystem
  • 3.3 Key Strategies and Developments
    • 3.3.1 BGI Genomics
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Products
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Key Personnel
      • 3.3.1.5 Analyst View
    • 3.3.2 MGI Tech Co., Ltd.
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Key Personnel
      • 3.3.2.5 Analyst View
    • 3.3.3 Macrogen, Inc.
      • 3.3.3.1 Overview
      • 3.3.3.2 Top Products/Product Portfolio
      • 3.3.3.3 Top Competitors
      • 3.3.3.4 Key Personnel
      • 3.3.3.5 Analyst View
    • 3.3.4 Emerging Companies in the Metagenomics Market

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast